References
- Burnet F M. The concept of immunological surveillance. Prog Expt Tumor Res 1970; 13: 1–27
- Klein G, Klein E. Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: Contrasting consequences of host versus tumor evolution. Proc Natl Acad Sci USA 1977; 78: 3915–3919
- Kamo I, Friedman H. Immunosuppression and the role of suppressive factors in cancer. Adv Cancer Res 1977; 25: 271–321
- Hellstrom I, Hellstrom K E, Sjorgen H O, et al. Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity. Int J Cancer 1971; 8: 185–191
- Alexander P. Escape from immune destruction by the host through shedding of surface antigens: Is this a characteristic shared by malignant and embryonic cells?. Cancer Res 1974; 34: 2077–2082
- Essex M. Feline leukemia and sarcoma virus. Viral Oncology, G Klein. Raven Press, New York 1980; 205–209
- Essex M, Sliski A, Cotter S M, et al. Immunosurveillance of naturally occurring feline leukemia. Science 1975; 190: 790–792
- Essex M. Immunity to leukemia, lymphoma and fibrosarcoma in cats: A case for immunosurveillance. Contemp Topics Immunobiol 1977; 6: 71–106
- Snyder H W, Jr, Jones F R, Day N K, et al. Isolation and characterization of circulating feline leukemia virus immune complexes in plasma of persistently infected pet cats removed by ex vivo immunosorption. J Immunol 1982; 128: 2726–2730
- Theilen G H, Kawakami G, Rush J D, et al. Replication of cat leukemia virus in cell suspension cultures. Nature 1969; 222: 589–590
- Sliski A H, Essex M, Meyer C, et al. Feline oncornavirus-associated cell membrane antigen (FOCMA): Expression on feline sarcoma virus transformed nonproducer mink cells. Science 1977; 196: 1336–1339
- Donner L, Turek L P, Ruscetti S K, et al. Transformation-defective mutants of feline sarcoma virus which express a product of the viral src gene. J Virol 1980; 35: 129–140
- Rosenberg Z F, Sahagan B G, Worley M B, et al. Transformation with subgenomic fragments of feline sarcoma virus proviral DNA. Virology 1981; 112: 496–504
- Chen A P, Essex M, Shadduck J A, et al. Retrovirus-encoded transformation-specific polyproteins: Expression coordinated with malignant phenotype in cells from different germ layers. Proc Natl Acad Sci USA 1981; 78: 3915–3919
- Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 1970; 227: 680–685
- Bonner W M, Laskey R A. Film detection method for tritium-labeled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem 1974; 46: 83–88
- Bolognesi D P, Collins S J, Leis J P, et al. Role of carbohydrate in determining the immunochemical properties of the major glycoprotein (gp71) of Friend murine leukemia virus. J Virol 1975; 16: 1453–1463
- Krantz M J, Strand M, August J T. Biochemical and immunological characterization of the major envelope glycoprotein gp69/71 and degradation fragments from Rauscher leukemia virus. J Virol 1977; 22: 804–815
- Lostrom M E, Stone M R, Tarn M, et al. Monoclonal antibodies against murine leukemia viruses: Identification of six antigenic determinants on the p15(E) and gp70 envelope proteins. Virology 1979; 98: 336–350
- Coffin J M, Varmus H E, Bishop J M, et al. A proposal for naming host cell-derived inserts in retrovirus genomes. J Virol 1981; 40: 953–957
- Stephenson J R, Khan A S, Sliski A H, et al. Feline oncor-navirus-associated cell membrane antigen (FOCMA): Identification of an immunologically cross-reactive feline sarcoma virus coded protein. Proc Natl Acad Sci USA 1977; 74: 5608–5612
- Barbacid M A, Lauver A V, Devare S G. A biochemical and immunological characterization of polyproteins coded for by the McDonough, Gardner-Arnstein, and Snyder-Theilen strains of feline sarcoma virus. J Virol 1980; 33: 196–207
- Van de Ven W JM, Reynolds F H, Stephenson J R. The nonstructural components of polyproteins encoded by replication-defective mammalian transforming retroviruses are phosphorylated and have associated protein kinase activity. Virology 1980; 101: 185–197
- Neil J C, Smart J E, Hayman M J, et al. Polypeptides of feline leukemia virus: A glycosylated gag-related protein is released into culture fluids. Virology 1980; 105: 250–253
- Bolognesi D P, Langlois A J, Schafer W. Polypeptides of mammalian oncornaviruses. IV. Structural components of murine leukemia virus released as soluble antigens in cell culture. Virology 1975; 68: 550–555
- Hardy W D, Jr, Hess P W, MacEwen E G, et al. The biology of feline leukemia virus in the natural environment. Cancer Res 1976; 36: 582–588
- Francis D P, Essex M, Cotter S M, et al. Feline leukemia virus infections: The significance of chronic viremia. Leukemia Res 1979; 3: 436–441
- Mathes L E, Olsen R G, Hebebrand L C, et al. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus. Cancer Res 1979; 39: 950–955
- Snyder H W, Jr, Stockert E, Fleissner E. Characterization of molecular species carrying Gross cell surface antigen. J Virol 1977; 23: 302–314
- Collins J J, Bolio L D, Denny T P, et al. Interspecies determinants of Friend leukemia virus antigens involved in cytolysis of virus-producing cells. J Virol 1977; 21: 113–119
- Snyder H W, Jr, Hardy W D, Jr, Zuckerman E E, et al. Characterization of a tumor specific antigen on the surface of feline lymphosarcoma cells. Nature 1978; 275: 656–657